ProCE Banner Series

How Can Primary Care Providers Take an Expanded Role in HBV Management? Symposium 3 on Key Questions in Timely Management of HBV and HDV

In this live webinar, a panel of expert primary care providers (PCPs) will explore how early and sustained HBV care can be enhanced by expanding the role of PCPs in HBV management, including on and off treatment monitoring, HBV treatment initiation, HCC surveillance, HDV screening, and perinatal HBV management.

  AMA
Who Should Attend

This program is intended for physicians, both specialists and primary care providers, and other healthcare professionals who care for patients with HBV and/or HDV infection or patients at risk for infection.

All Events

How Can Primary Care Providers Take an Expanded Role in HBV Management? Symposium 3 on Key Questions in Timely Management of HBV and HDV

Past Events

April

11

2024

2:30 PM - 3:30 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Richard R. Andrews, MD, MPH

President, Houston Viral Hepatitis Task Force
Former Co-Chair, National Task Force on Hepatitis B
Board-Certified Family Medicine
Addiction Medicine Physician
Houston, Texas

ProCE Banner Faculty
Amy S. Tang, MD

Former Co-Chair, National Task Force on Hepatitis B
Director of Immigrant Health
North East Medical Services
San Francisco, California

ProCE Banner Faculty
Su Wang, MD, MPH, FACP

Medical Director
Center for Asian Health and Viral Hepatitis Programs
Cooperman Barnabas Medical Center
RWJBarnabas-Rutgers Medical Group
Associate Member
Health Care Policy and Aging Research
The Rutgers Institute for Health
Senior Advisor
Global Health, Hepatitis B Foundation
Florham Park, New Jersey

Topics

  • Welcome, Opening Remarks, and Baseline Assessment
  • Identifying Practice Settings Where PCPs Should Have a Role in HBV Management
  • Implementation Strategies
  • Leveraging a Team-Based Approach
  • Conclusion and Question and Answer Session

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to enhance learners’ knowledge and competence in providing timely screening and treatment for HBV and HDV with a goal of both individual patient benefit and progress toward HBV elimination goals. 

Target Audience
This program is intended for physicians, both specialists and primary care providers, and other healthcare professionals who care for patients with HBV and/or HDV infection or patients at risk for infection. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Formulate strategies to optimize HBV and HDV screening and treatment in varied clinical practice settings to achieve favorable patient outcomes

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC and Hepatitis B Foundation. Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC, in partnership with Hepatitis B Foundation.

Supported by an educational grant from Gilead Sciences, Inc.